Additionally, promising therapies to reduce its elimination to limit tumor progression include heparanase and MMP inhibition, synthetic proteoglycans mimicking SDC1, and strategies targeting growth factor interactions [26,28,102]. The gene discussed is SDC1; the disease is neoplasm.